| Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Y Cao, J Wang, F Jian, T Xiao, W Song, A Yisimayi, W Huang, Q Li, ... Nature 602 (7898), 657-663, 2022 | 1647 | 2022 |
| Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells Y Cao, B Su, X Guo, W Sun, Y Deng, L Bao, Q Zhu, X Zhang, Y Zheng, ... Cell 182 (1), 73-84. e16, 2020 | 1226 | 2020 |
| BA. 2.12. 1, BA. 4 and BA. 5 escape antibodies elicited by Omicron infection Y Cao, A Yisimayi, F Jian, W Song, T Xiao, L Wang, S Du, J Wang, Q Li, ... Nature 608 (7923), 593-602, 2022 | 1150 | 2022 |
| Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution Y Cao, F Jian, J Wang, Y Yu, W Song, A Yisimayi, J Wang, R An, X Chen, ... Nature 614 (7948), 521-529, 2023 | 572 | 2023 |
| Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron Z Cui, P Liu, N Wang, L Wang, K Fan, Q Zhu, K Wang, R Chen, R Feng, ... Cell 185 (5), 860-871. e13, 2022 | 355 | 2022 |
| Circular RNA vaccines against SARS-CoV-2 and emerging variants L Qu, Z Yi, Y Shen, L Lin, F Chen, Y Xu, Z Wu, H Tang, X Zhang, F Tian, ... Cell 185 (10), 1728-1744. e16, 2022 | 325 | 2022 |
| Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy S Du, Y Cao, Q Zhu, P Yu, F Qi, G Wang, X Du, L Bao, W Deng, H Zhu, ... Cell 183 (4), 1013-1023. e13, 2020 | 235 | 2020 |
| ACE2 binding and antibody evasion in enhanced transmissibility of XBB. 1.5 C Yue, W Song, L Wang, F Jian, X Chen, F Gao, Z Shen, Y Wang, X Wang, ... The Lancet Infectious Diseases 23 (3), 278-280, 2023 | 192 | 2023 |
| Fast evolution of SARS-CoV-2 BA. 2.86 to JN. 1 under heavy immune pressure S Yang, Y Yu, Y Xu, F Jian, W Song, A Yisimayi, P Wang, J Wang, J Liu, ... The Lancet Infectious Diseases 24 (2), e70-e72, 2024 | 176 | 2024 |
| Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines Y Cao, A Yisimayi, Y Bai, W Huang, X Li, Z Zhang, T Yuan, R An, J Wang, ... Cell research 31 (7), 732-741, 2021 | 150 | 2021 |
| Characterization of the enhanced infectivity and antibody evasion of Omicron BA. 2.75 Y Cao, W Song, L Wang, P Liu, C Yue, F Jian, Y Yu, A Yisimayi, P Wang, ... Cell host & microbe 30 (11), 1527-1539. e5, 2022 | 138 | 2022 |
| Antigenicity and infectivity characterisation of SARS-CoV-2 BA. 2.86 S Yang, Y Yu, F Jian, W Song, A Yisimayi, X Chen, Y Xu, P Wang, J Wang, ... The Lancet Infectious Diseases 23 (11), e457-e459, 2023 | 97 | 2023 |
| Fast compressed sensing analysis for super-resolution imaging using L1-homotopy HP Babcock, JR Moffitt, Y Cao, X Zhuang Optics express 21 (23), 28583-28596, 2013 | 94 | 2013 |
| Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting A Yisimayi, W Song, J Wang, F Jian, Y Yu, X Chen, Y Xu, S Yang, X Niu, ... Nature 625 (7993), 148-156, 2024 | 86 | 2024 |
| Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine Y Cao, X Hao, X Wang, Q Wu, R Song, D Zhao, W Song, Y Wang, ... Cell research 32 (1), 107-109, 2022 | 77 | 2022 |
| Further humoral immunity evasion of emerging SARS-CoV-2 BA. 4 and BA. 5 subvariants F Jian, Y Yu, W Song, A Yisimayi, L Yu, Y Gao, N Zhang, Y Wang, F Shao, ... The Lancet Infectious Diseases 22 (11), 1535-1537, 2022 | 75 | 2022 |
| Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents Y Cao, F Jian, Z Zhang, A Yisimayi, X Hao, L Bao, F Yuan, Y Yu, S Du, ... Cell reports 41 (12), 2022 | 71 | 2022 |
| A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2 Z Jia, K Wang, M Xie, J Wu, Y Hu, Y Zhou, A Yisimayi, W Fu, L Wang, ... Protein & Cell, pwae033, 2024 | 50 | 2024 |
| Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding F Jian, L Feng, S Yang, Y Yu, L Wang, W Song, A Yisimayi, X Chen, Y Xu, ... PLoS Pathogens 19 (12), e1011868, 2023 | 44 | 2023 |
| Structures of SARS-CoV-2 B. 1.351 neutralizing antibodies provide insights into cocktail design against concerning variants S Du, P Liu, Z Zhang, T Xiao, A Yasimayi, W Huang, Y Wang, Y Cao, ... Cell research 31 (10), 1130-1133, 2021 | 34 | 2021 |